SGLT2 inhibitors use not tied to significant risk of amputations in diabetics: Study
Singapore: A meta-analysis of 15 randomized controlled trials of SGLT2 inhibitors for diabetes and non-diabetes patients, showed no significant difference in amputation risk for the various SGLT2...
Source: medicaldialogues.in